Skip to content

effects of Asparagus racemosus (shatavari) and Abutilon indicum (Atibala) with D3 in patients with Janu Sandhigat vata (osteoarthritis of knee).

A Randomized, Controlled, Open Label clinical trial of Asparagus racemosus (Shatavari), Abutilon indicum (Atibala) with Add-on effect of Vitamin D3 in patients with Sandhigata Vata (Janusadhigata Vata) w.s.r. to osteoarthritis of knee joint. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107661
Enrollment
164
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

Vijay Madhukarrao Maske
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients had chronic osteoarthritis of the knee as diagnosed by ACR diagnostic guidelines. Patients had Sandhi shotha (Swelling), Prasaran Akunchan Kashtata (Difficulty in Moving of Joint), Savedana (Pain).

Exclusion criteria

Exclusion criteria: Patients with Acute Infective arthritis, Patients with osteoarthritis not affecting the knees, Patients with known allergy to any of the constituents of the study drug, Patients who were pregnant or lactating

Design outcomes

Primary

MeasureTime frame
To observe the reduction in lakshana of sandhigata vata.Timepoint: at baseline, 31th day, 61th day, 91th day

Secondary

MeasureTime frame
to observe the changes in oral analgesic requirement of patientTimepoint: at baseline, 31th day, 61th day, 91th day

Countries

India

Contacts

Public ContactVijay Madhukarrao Maske

Government Ayurved College, Vazirabad, Nanded.

vmmaske3089@gmail.com8669007610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026